Mounjaro Beats Ozempic for Weight Loss in Early Trial

[ad_1] By Robin Foster HealthDay Reporter (HealthDay) WEDNESDAY, Nov. 29, 2023 (Healthday News) — The diabetes drug Mounjaro prompted more weight loss among overweight and obese adults than Ozempic did in a real-world setting, researchers report. Both Mounjaro (tirzepatide) and Ozempic (semaglutide) mimic the effects of the gut hormone GLP-1, which triggers insulin production, helps … Read more

Lilly’s Mounjaro Leads to More and Faster Weight Loss Than Novo Obesity Drug, Data Analysis Finds

[ad_1] (Reuters) – Overweight or obese adults lost more weight and shed pounds faster using Eli Lilly’s Mounjaro than those taking Novo Nordisk’s popular rival weight loss drug, according to an analysis of health records and other data. Within one year of starting treatment, 42.3% of those taking tirzepatide – the active ingredient in Mounjaro … Read more

Almost 400,000 Deaths in Europe in 2021 Attributable to Filthy Air -EU Report

[ad_1] BRUSSELS (Reuters) – Almost 400,000 deaths in Europe in 2021 were related to three main air pollutants and some could have been avoided if pollutants had been reduced to World Health Organisation-recommended levels, an EU report said on Friday. The European Environment Agency (EEA) said that within the European Union, pollution caused by fine … Read more

Boom in Weight-Loss Drugs to Drive up US Employers’ Medical Costs in 2024

[ad_1] By Leroy Leo and Khushi Mandowara (Reuters) – Booming demand for newer weight-loss and diabetes drugs is expected to accelerate the rise in medical expenses for employers in the United States next year, staff health benefits consultant Mercer said on Friday. GLP-1 medications approved by the U.S. Food and Drug Administration could contribute between … Read more